Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Dent ; 43(8): 965-72, 2015 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-26057085

RESUMO

OBJECTIVE: The aim of this clinical randomized double-blind split-mouth study was to assess the effectiveness of a 6% hydrogen peroxide with nitrogen-doped titanium dioxide light activated bleaching agent. METHOD: 31 patients were treated with: one upper hemiarcade with a 35% hydrogen peroxide bleaching agent and the other hemiarcade with a 6% hydrogen peroxide. Two applications were completed each treatment session and three sessions were appointed, with one week interval between them. Tooth colour was registered each session and 1 week and 1 months after completing the treatment by spectrophotometer, registering parameters L*, a* and b*, and subjectively using VITA Classic guide. Tooth sensitivity was registered by VAS and patient satisfaction and self-perception result was determined using OHIP-14. Tooth colour variation and sensitivity were compared between both bleaching agents. RESULTS: Both treatment showed a change between baseline colour and all check-points with a ΔE=5.57 for 6% and of ΔE=7.98 for the 35% one month after completing the (p<0.05). No statistical differences were seen when subjective evaluations were compared. Also, no differences were seen in tooth sensitivity between bleaching agents. OHIP-14 questionnaire demonstrated a significant change for all patients after bleaching. CONCLUSIONS: A 6% hydrogen peroxide with nitrogen-doped titanium dioxide light activated agent is effective for tooth bleaching, reaching a ΔE of 5.57 one month after completing the treatment, with no clinical differences to a 35% agent neither in colour change or in tooth sensitivity. CLINICAL SIGNIFICANCE: A low concentration hydrogen peroxide bleaching agent may reach good clinical results with less adverse effects.


Assuntos
Peróxido de Hidrogênio/administração & dosagem , Clareadores Dentários/administração & dosagem , Clareamento Dental/métodos , Adulto , Método Duplo-Cego , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos , Feminino , Humanos , Peróxido de Hidrogênio/efeitos adversos , Masculino , Satisfação do Paciente , Espectrofotometria , Titânio/administração & dosagem , Titânio/efeitos adversos , Clareamento Dental/efeitos adversos , Resultado do Tratamento , Adulto Jovem
2.
J Dent Res ; 93(7 Suppl): 66S-71S, 2014 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-24868014

RESUMO

OBJECTIVES: The purpose of this randomized double-blinded clinical trial was to test the efficacy and tooth sensitivity promoted by the use of an in-office 15% H(2)O(2) bleaching agent containing nanoparticles of TiO_N photocatalyzed with LED/laser light (HP15) and a control of 35% H2O2 (HP35). METHODS: Forty healthy volunteers, both sexes, aged 18 to 25 yr, were randomly distributed in 2 groups: HP15 (n = 20) was treated in 3 sessions of 48 min each, and HP35 (n = 20) was treated in 3 sessions of 45 min each. The efficacy (E) was evaluated by ΔE values measured via reflectance spectroscopy. The tooth sensitivity (S) was analyzed by visual analog scale (low, average, high, very high). The absolute risk reduction and the number needed to treat index were calculated. The data were analyzed by mixed repeated measures analysis of variance with Bonferroni-correction t test (α = 0.05). RESULTS: For the efficacy, significant differences were found for number of bleaching sessions (p = .0001; [Formula: see text] = 0.73 and π = 1.000) and for the interaction of number of sessions and bleaching protocols (p = .0001; [Formula: see text] = 0.319 and π = 1.000. The tooth sensitivity level showed significant differences only between the bleaching protocols. Absolute risk reduction calculated was 52% and number needed to treat, 1.92. CONCLUSIONS: The bleaching agent with the lower concentration (HP15) promoted lower levels of tooth sensitivity and presented greater efficacy compared to the control (HP35) in patients between 18 and 25 yr old. The limitation of short-term evaluation did not provide information about the longevity of the tooth bleaching (Brazilian Clinical Trials Registry Re Bec no. U1111-1150-4466).


Assuntos
Peróxido de Hidrogênio/administração & dosagem , Nitrogênio/administração & dosagem , Fármacos Fotossensibilizantes/administração & dosagem , Titânio/administração & dosagem , Clareamento Dental/métodos , Adolescente , Adulto , Sensibilidade da Dentina/prevenção & controle , Método Duplo-Cego , Feminino , Humanos , Análise de Intenção de Tratamento , Lasers Semicondutores/uso terapêutico , Masculino , Nanopartículas/química , Medição da Dor/métodos , Espectrofotometria/métodos , Fatores de Tempo , Clareadores Dentários/administração & dosagem , Resultado do Tratamento , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA